Back to School: How biopharma can reboot drug development. Access exclusive analysis here

GLQ223 alpha-trichosanthin data

GNLB (Redwood City, Calif.) completed analysis of its Phase II trial,

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE